June 30, 2020 —  BioCardia, Inc. announced that the company has resumed cases in the CardiAMP Heart Failure Trial. The first patient procedure completed since elective procedures were paused due to COVID-19 took place at Morton Plant Hospital in Clearwater, Florida this month. New consents have also taken place at additional centers. 

June 29, 2020 — Boston Scientific received U.S. Food and Drug Administration (FDA) 510(k) clearance for the LUX-Dx Insertable Cardiac Monitor (ICM) System, a new, long-term diagnostic device implanted in patients to detect arrhythmias associated with conditions such as atrial fibrillation (AF), cryptogenic stroke and syncope.

June 29, 2020 — A type of smart magnetic resonance imaging (MRI) scan used in people with heart disease could help assess whether children's cancers are especially aggressive and spot early signs that targeted treatments are working, a new study suggests.

June 26, 2020 — Abbott announced new data from the company's LightLab Initiative that showed optical coherence tomography (OCT) imaging significantly changes how physicians decide to treat a vessel compared to traditional angiography by providing physicians improved visualization within a patient's blood vessels. Data from the study revealed physicians altered their treatment strategy in 88 percent of coronary artery blockages based on new information provided by OCT.

June 26, 2020 – New data from the Global SYMPLICITY Registry (GSR) showed that renal denervation (RDN) with the Medtronic Symplicity Renal Denervation System significantly reduced blood pressure (BP) in uncontrolled hypertension patients out to three years independent of anti-hypertension medication burden. The data were presented virtually as part of the PCR e-Course 2020 this week. 

June 23, 2020 – Heart valve start-up Foldax is looking to reinventing several aspects of the prosthetic heart valve, from material used, design and use of robotic manufacturing, announced the closing of a $20 million Series D round of funding.

June 23, 2020 — Philips announced the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) for the company’s HeartStart FR3 (models 861388 and 861389) and HeartStart FRx (model 861304) automated external defibrillators (AEDs), and their supporting accessories, including batteries and pads.

June 23, 2020 — The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Program status for the preCardia catheter-based system for treating volume overload in patients with acutely decompensated heart failure (ADHF). 

Prior to January 2020 when clinicians read about the history of the 1918 flu, and epidemiologists predicted we were overdue for another serious pandemic, the question in the back of many people's minds was how they would act when the arrival day came for a new modern plague. In just a couple months, health systems and their clinicians worldwide went from wondering to being thrown into the thick of that scenario with the arrival of COVID-19 (SARS-CoV-2).

June 19, 2020 — SMT (Sahajanand Medical Technologies Pvt. Ltd) said it acquired of the structural heart medical device firm Vascular Concepts. The acquisition was completed May 27. 

The company recently gained European CE mark for its Hydra transcatheter aortic valve implantation (TAVI) system in early June 2020.

Vascular Concept will retain its distinct brand and independence and Swaminathan Jayaraman, CEO of Vascular Concept, will continue to manage the operation of the company.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now